FDA to investigate metals found in tampons after study; study's co-author 'excited' over probe
The FDA will now investigate metals found in tampons following the results of a recent study. The study's co-author weighs in ...
Elon Musk’s Neuralink brain chip receives FDA’s ‘breakthrough device’ status — and could help blind people see again
Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind ...
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Neuralink Brain Implant Wins an FDA Nod to Tackle Blindness
The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a ...
Food Safety News2d
FDA warns food companies for violations in acidified foods and seafood imports
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Elon Musk's Neuralink gets FDA's 'breakthrough device' tag for this
Elon Musk's Neuralink has been granted the FDA's breakthrough device designation for its vision implant, Blindsight. This ...
Investopedia8d
Food and Drug Administration (FDA): What It Is and Does
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
STAT16h
FDA awards Novartis expanded approval for breast cancer therapy
The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
For CNM-Au8, Clene has more than 700 patient-years of safety data that show no significant safety concerns or safety trends identified. No serious adverse events (SAEs) have been identified as related ...